11 Results

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. Chaft
    Chaft
  4. Ladanyi
    Ladanyi
  5. Paik
    Paik
  6. Plodkowski
    Plodkowski
  7. Rusch
    Rusch
  8. Schoenfeld
    Schoenfeld
  9. Sima
    Sima
  10. Yu
    Yu

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Thoracic Oncology (11)
  4. Body Imaging Service (4)
  5. Radiology, Department of (4)
  6. GSK Faculty (3)
  7. Hematologic Malignancies, Division of (3)
  8. Human Oncology and Pathogenesis Program (3)
  9. Tow Center for Developmental Oncology (TCDO) (3)
  10. Biostatistics Service (2)
  1. "anaplastic lymphoma kinase"
  2. "Department of Medicine"
  3. "Thoracic Oncology"
  4. "Gregory Riely"
Formats
  1. Journal Article (10)
  2. Conference Paper (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Thoracic Oncology (11)
  4. Body Imaging Service (4)
  5. Radiology, Department of (4)
  6. GSK Faculty (3)

More Groups

People
  1. Gregory Riely (11)
  2. Marc Ladanyi (3)
  3. Mark Kris (3)
  4. Adam Schoenfeld (2)
  5. Andrew Plodkowski (2)
  6. Camelia Sima (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Thoracic Oncology (2)
  2. Molecular Cancer Therapeutics (2)
  3. Annals of Oncology (1)
  4. Cancer (1)
  5. Clinical Pharmacology & Therapeutics (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Ireland Ltd. (1)
  5. Massachusetts Medical Society (1)
  6. Mosby Elsevier (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MIG6 mediates adaptive and acquired resistance to ALK/ROS1 fusion kinase inhibition through EGFT bypass signaling
    Journal Article

    Chen, N.; Tyler, L. C.; Le, A. T.; Welsh, E. A.; Fang, B.; Elliott, A.; Davies, K. D.; Danhorn, T.; Riely, G. J.; Ladanyi, M.; more...
    Molecular Cancer Therapeutics (2024)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive NSCLC refractory to second-generation ALK inhibitors
    Journal Article

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S. R.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Brigatinib in patients With alectinib-refractory ALK-positive NSCLC
    Journal Article

    Lin, J. J.; Zhu, V. W.; Schoenfeld, A. J.; Yeap, B. Y.; Saxena, A.; Ferris, L. A.; Dagogo-Jack, I.; Farago, A. F.; Taber, A.; Traynor, A.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer
    Journal Article

    Dagogo-Jack, I.; Shaw, A. T.; Riely, G. J.
    Clinical Pharmacology & Therapeutics (2017)

    Fulltext@MSK | Save
  • Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small-cell lung cancer and brain metastases
    Journal Article

    Costa, D. B.; Shaw, A. T.; Ou, S. H. I.; Solomon, B. J.; Riely, G. J.; Ahn, M. J.; Zhou, C. C.; Shreeve, M.; Selaru, P.; Polli, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
    Journal Article

    Halpenny, D. F.; Riely, G. J.; Hayes, S.; Yu, H.; Zheng, J.; Moskowitz, C. S.; Ginsberg, M. S.
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • Ceritinib in ALK-rearranged non-small-cell lung cancer
    Journal Article

    Shaw, A. T.; Kim, D. W.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
    Journal Article

    Shaw, A. T.; Varghese, A. M.; Solomon, B. J.; Costa, D. B.; Novello, S.; Mino-Kenudson, M.; Awad, M. M.; Engelman, J. A.; Riely, G. J.; Monica, V.; more...
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas
    Journal Article

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C. S.; Ang, D.; Dogan, S.; Miller, V. A.; Ladanyi, M.; Kris, M. G.; Riely, G. J.
    Cancer (2012)

    Fulltext@MSK | Save